Shares of Cybin, Inc. ($CYBN) surged as much as 10% on Monday, reaching their highest level since May, following the ...

Experts have discovered that salmonella has been depleting a key protein which the body’s own immune cells need to function.

Nipocalimab is a fully human monoclonal antibody that blocks FcRn and decreases levels of circulating IgG antibodies.

A revolutionary breakthrough in cataract treatment is on the horizon, with the emergence of C-KAD, a new eye drop therapy.

A clinical trial has shown promising results in treating brain tumours in children using an immune-cell therapy known as ...

Music therapy reduces distress and improves well-being in advanced dementia by meeting unmet needs, enhancing ...

Johnson & Johnson announced that the U.S. Food and Drug Administration has granted nipocalimab Breakthrough Therapy designation for the ...

Johnson & Johnson (J&J) has announced that its anti-FcRn antibody nipocalimab has become the first investigational therapy to ...

Researchers from the Center for Regenerative Medicine (CReM) and the Department of Medicine at Boston Medical Center (BMC) ...

Medical experts report breakthrough strategies for managing chronic pain, swelling and stiffness through a combination of ...

Johnson & Johnson said its nipocalimab treatment for adults living with moderate-to-severe Sjögren's disease has received breakthrough therapy designation from the Food and Drug Administration.

A Seattle biotech company is working on a tweak to gene expression that could shut down hepatitis B (HBV), one of the viruses ...